HRTS holdings

All 45 positions of Tema ETF Trust Tema Heart & Health ETF.

Download CSV

Positions

Top 10 weight

49.1%

Effective holdings

25.2

1 / sum of squared weights

In stocks

99.2%

In bonds

0.0%

Outside the US

25.0%

Asset mix

Equity99.2%
Cash0.7%

Sectors

78% of stocks classified

Health Care70.5%
Technology6.6%

Countries

United States74.1%
Switzerland7.9%
Denmark7.0%
United Kingdom4.0%
Israel2.1%
Ireland1.9%
Japan1.3%
Canada0.9%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	11.52%	$6.0M	5,413	US
2	UNHUNITEDHEALTH GROUP INCORPORATED (Delaware)	Equity	5.24%	$2.7M	7,159	US
3	Novo Nordisk A/S	Equity	5.24%	$2.7M	59,455	DK
4	RHHBYROCHE HOLDING LTD S/ADR	Equity	4.50%	$2.3M	44,538	CH
5	MRKMerck & Co., Inc.	Equity	4.27%	$2.2M	18,672	US
6	AstraZeneca PLC	Equity	4.00%	$2.1M	11,178	GB
7	TMOThermo Fisher Scientific, Inc.	Equity	3.97%	$2.1M	4,185	US
8	JNJJohnson & Johnson	Equity	3.59%	$1.9M	8,274	US
9	GILDGilead Sciences Inc	Equity	3.43%	$1.8M	13,261	US
10	Novartis AG	Equity	3.38%	$1.8M	11,627	CH
11	RVMDRevolution Medicines, Inc. Common Stock	Equity	3.33%	$1.7M	10,971	US
12	VRTXVertex Pharmaceuticals Inc	Equity	2.93%	$1.5M	3,398	US
13	DHRDanaher Corporation	Equity	2.66%	$1.4M	7,557	US
14	ABTAbbott Laboratories	Equity	2.61%	$1.4M	15,809	US
15	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	2.59%	$1.3M	20,327	US
16	CYTKCytokinetics Inc.	Equity	2.52%	$1.3M	17,069	US
17	ABBVABBVIE INC.	Equity	2.40%	$1.2M	5,714	US
18	BMYBristol-Myers Squibb Co.	Equity	2.09%	$1.1M	18,939	US
19	TEVATeva Pharmaceutical Industries Limited	Equity	2.06%	$1.1M	30,273	IL
20	DXCMDexCom, Inc.	Equity	1.92%	$996K	13,512	US
21	AMGNAmgen Inc	Equity	1.91%	$992K	2,946	US
22	Medtronic PLC	Equity	1.88%	$975K	13,203	IE
23	EWEdwards Lifesciences Corp	Equity	1.75%	$907K	10,488	US
24	MCKMcKesson Corporation	Equity	1.71%	$888K	1,196	US
25	REGNRegeneron Pharmaceuticals Inc	Equity	1.67%	$866K	1,408	US
26	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	1.45%	$755K	1,519	US
27	BSXBoston Scientific Corp.	Equity	1.42%	$738K	15,285	US
28	Chugai Pharmaceutical Co Ltd	Equity	1.33%	$690K	13,915	JP
29	ISRGIntuitive Surgical Inc.	Equity	1.30%	$675K	1,590	US
30	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.14%	$590K	1,954	US
31	ARWRArrowhead Research Corporation	Equity	1.09%	$564K	7,240	US
32	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.92%	$476K	9,647	US
33	XENEXenon Pharmaceuticals Inc	Equity	0.88%	$459K	8,393	CA
34	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.83%	$428K	5,599	US
35	PODDInsulet Corporation	Equity	0.79%	$411K	2,835	US
36	Ascendis Pharma A/S	Equity	0.76%	$393K	1,755	DK
37	First American Treasury Obliga	Cash	0.72%	$373K	373,497	US
38	INSMInsmed, Inc.	Equity	0.71%	$369K	3,449	US
39	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.60%	$311K	10,049	US
40	VKTXViking Therapeutics, Inc	Equity	0.54%	$280K	8,538	US
41	MBXMBX Biosciences, Inc. Common Stock	Equity	0.53%	$276K	8,761	US
42	Zealand Pharma A/S	Equity	0.52%	$268K	5,293	DK
43	Gubra A/S	Equity	0.48%	$250K	4,487	DK
44	NTLAIntellia Therapeutics, Inc	Equity	0.38%	$195K	13,892	US
45	GPCRStructure Therapeutics Inc. American Depositary Shares	Equity	0.35%	$180K	4,583	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	Novo Nordisk A/S	2.15%	5.24%	+90.7%	Feb 28, 2026 → May 31, 2026 SEC
Exit	CORMasimo Corp	1.36%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	JNJJohnson & Johnson	4.85%	3.59%	−22.4%	Feb 28, 2026 → May 31, 2026 SEC
Increase	CYTKCytokinetics Inc	1.47%	2.52%	+31.9%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	BSXBoston Scientific Corp	2.47%	1.42%	−12.8%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	RHHBYRoche Holding AG	5.46%	4.50%	−11.1%	Feb 28, 2026 → May 31, 2026 SEC
New position	XENEXenon Pharmaceuticals Inc	—	0.88%	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	AstraZeneca PLC	4.81%	4.00%	−10.9%	Feb 28, 2026 → May 31, 2026 SEC
New position	Ascendis Pharma A/S	—	0.76%	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	ASNDAscendis Pharma A/S	0.75%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	Chugai Pharmaceutical Co Ltd	2.05%	1.33%	−16.9%	Feb 28, 2026 → May 31, 2026 SEC
Exit	CRNXCrinetics Pharmaceuticals Inc	0.64%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Increase	DXCMDexcom Inc	1.29%	1.92%	+41.2%	Feb 28, 2026 → May 31, 2026 SEC
New position	STOKStoke Therapeutics Inc	—	0.60%	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	NBIXNeurocrine Biosciences Inc	0.57%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	ABBVAbbVie Inc	2.96%	2.40%	−17.8%	Feb 28, 2026 → May 31, 2026 SEC
New position	MBXMBX Biosciences Inc	—	0.53%	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	INSMInsmed Inc	1.19%	0.71%	−20.9%	Feb 28, 2026 → May 31, 2026 SEC
Increase	TEVATeva Pharmaceutical Industries	1.62%	2.06%	+16.2%	Feb 28, 2026 → May 31, 2026 SEC
Increase	BBIOBridgebio Pharma Inc	2.23%	2.59%	+10.9%	Feb 28, 2026 → May 31, 2026 SEC
New position	GPCRStructure Therapeutics Inc	—	0.35%	—	Feb 28, 2026 → May 31, 2026 SEC
Decrease	VKTXViking Therapeutics Inc	0.85%	0.54%	−37.6%	Feb 28, 2026 → May 31, 2026 SEC
Increase	PODDInsulet Corp	1.04%	0.79%	+23.0%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	EWEdwards Lifesciences Corp	1.86%	1.75%	−10.6%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	ARWRArrowhead Pharmaceuticals Inc	1.03%	1.09%	−18.2%	Feb 28, 2026 → May 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.